Repligen Corp at Jefferies Healthcare Conference Transcript
All right. Good afternoon, everybody. Thanks for joining us. We're going to get started. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandon Couillard, I cover the life sciences space. Very happy to have Repligen with us back at the conference this year. And here to share an update with us, Jon Snodgres, CFO. Jon?
Well, thank you, Brandon, and good day, everybody. Pleasure today to be here to give you an update on Repligen, and how we continue to move technology forward in our industry to become a leading company in bioprocessing. Sorry that we have to do it right after lunch. So hopefully, everybody has got a little bit of energy to get through this. No food comas here.
Anyway, really quickly, I'll start with a company overview, talk a little bit about how we've developed our portfolio and our customer base over the years, and we'll get into some of the more detailed stuff on technology.
So I think this chart
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |